DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
AVAH logo

Aveanna Healthcare Holdings Inc. Stock Price

NasdaqGS:AVAH Community·US$3.1b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 14 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

AVAH Share Price Performance

US$14.31
6.08 (73.88%)
​
US$13.90
Fair Value
US$14.31
6.08 (73.88%)
2.9% overvalued intrinsic discount
US$13.90
Fair Value
Price US$14.31
AnalystConsensusTarget US$13.90
AnalystHighTarget US$16.00
AnalystLowTarget US$8.00
Thu, 3 Sep 26
Fair ValueUS$13.90
Share Pricen/a

AVAH Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$13.9 2.9% overvalued intrinsic discount

Improved Earnings Visibility and Liquidity Changes Will Shape Capacity Expansion

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$16 10.6% undervalued intrinsic discount

Aging Demographics Will Expand The Home Care Market

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$8 78.9% overvalued intrinsic discount

Medicaid Cuts And Rising Wages Will Erode Margins

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AVAH logo
Aveanna Healthcare Holdings
2.9% overvalued intrinsic discount

Improved Earnings Visibility and Liquidity Changes Will Shape Capacity Expansion

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 3 Sep
Read Narrative
AVAH logo
Aveanna Healthcare Holdings
10.6% undervalued intrinsic discount

Aging Demographics Will Expand The Home Care Market

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 14 Aug
Read Narrative
AVAH logo
Aveanna Healthcare Holdings
78.9% overvalued intrinsic discount

Medicaid Cuts And Rising Wages Will Erode Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 2 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
AVAH logo

AVAH: Beat And Raise Progress Will Test Secular Tailwinds And Reimbursement Support

Fair Value: US$13.9 2.9% overvalued intrinsic discount
7 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
AVAH logo

AVAH: Future Upside Will Rely On Preferred Payor Mix And Reimbursement

Fair Value: US$16 10.6% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
AVAH logo

AVAH: Home Care Momentum And Preferred Payor Mix Will Support Margin Resilience

Fair Value: US$8 78.9% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with solid track record.

3 Risks
3 Rewards
View Full Analysis

Aveanna Healthcare Holdings Inc. Key Details

US$2.6b

Revenue

US$1.8b

Cost of Revenue

US$833.9m

Gross Profit

US$559.1m

Other Expenses

US$274.8m

Earnings

Last Reported Earnings
Jul 04, 2026
Next Reporting Earnings
n/a
1.26
32.04%
10.56%
507.9%
View Full Analysis

About AVAH

Founded
2016
Employees
19500
CEO
Jeffrey Shaner
WebsiteView website
www.aveanna.com

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Recent AVAH News & Updates

User avatar
Narrative Update • Sep 03

AVAH: Beat And Raise Progress Will Test Secular Tailwinds And Reimbursement Support

Aveanna Healthcare Holdings' updated analyst price target moves from $9.95 to $13.90. Analysts point to stronger Q2 results, higher long term growth assumptions, and improved margin expectations as key drivers behind the revision.
Seeking Alpha • Aug 31

Aveanna Healthcare: Increasing Earnings And Delevering Focus Make It An Appealing Stock

Summary Aveanna Healthcare Holdings demonstrates strong revenue and earnings growth, with a focus on private duty services and strategic M&A. AVAH trades at a low LTM P/E of 11.8x, reflecting its high leverage but also offering compelling value versus peers. Management targets reducing leverage below 3x, prioritizing cash-funded acquisitions and disciplined expansion to mitigate balance sheet risks. Long-term prospects are bright, with PDS rate increases in California and geriatric care expected to drive future growth, making AVAH an appealing long-term buy. Read the full article on Seeking Alpha

Recent updates

No updates

Aveanna Healthcare Holdings Inc. Competitors

ZBH logo

Zimmer Biomet Holdings

Symbol: NYSE:ZBH
Market cap: US$18.4b
SOLV logo

Solventum

Symbol: NYSE:SOLV
Market cap: US$15.3b
PEN logo

Penumbra

Symbol: NYSE:PEN
Market cap: US$12.6b
BTSG logo

BrightSpring Health Services

Symbol: NasdaqGS:BTSG
Market cap: US$12.6b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide